Zoetis receives EU approval for Poulvac Procerta HVT-ND poultry vaccine
Zoetis (NYSE:ZTS) announced that the European Commission (EC) granted marketing authorization for Poulvac Procerta HVT-ND, a recombinant vector vaccine designed to protect chickens against Newcastle disease (ND) and Marek’s disease.










